Comparison of Contents of Index Components in Granule,Dispensing Granule and Traditional Decoction of Wuzhuyu Tang

LIN Wei-xiong; LE Zhi-yong; CHE Hai-yan; LIU Yin-zhen; LIU Chong; WANG Hui

doi:10.13422/j.cnki.syfjx.2017130030

您当前的位置：

首页 >

文章列表页 >

Comparison of Contents of Index Components in Granule,Dispensing Granule and Traditional Decoction of Wuzhuyu Tang

更新时间：2024-01-04

- Comparison of Contents of Index Components in Granule,Dispensing Granule and Traditional Decoction of Wuzhuyu Tang
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 23, Issue 13, Pages: 30-34(2017)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2017130030
  CLC： O657.72;R286.0
- Published：2017
- 稿件说明：
移动端阅览
LIN Wei-xiong, LE Zhi-yong, CHE Hai-yan, et al. Comparison of Contents of Index Components in Granule,Dispensing Granule and Traditional Decoction of Wuzhuyu Tang[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(13): 30-34.
DOI：

LIN Wei-xiong, LE Zhi-yong, CHE Hai-yan, et al. Comparison of Contents of Index Components in Granule,Dispensing Granule and Traditional Decoction of Wuzhuyu Tang[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(13): 30-34. DOI： 10.13422/j.cnki.syfjx.2017130030.

摘要

目的：比较吴茱萸汤颗粒剂、配方颗粒剂与传统汤剂中指标性成分的含量差异。方法：采用不同高效液相色谱法（HPLC）测定吴茱萸颗粒剂、配方颗粒剂与传统汤剂中吴茱萸碱、吴茱萸次碱、人参皂苷Re和人参皂苷Rb1的含量，并对含量测定方法进行考察。结果：颗粒剂、配方颗粒剂与传统汤剂中吴茱萸碱和吴茱萸次碱质量浓度之和分别为47.32，13.49，12.60 mg·L-1，颗粒剂、配方颗粒剂中二者的质量浓度之和分别为传统汤剂的3.76，1.07倍；人参皂苷Re和人参皂苷Rb1质量浓度之和分别为335.23，345.28，307.39 mg·L-1。颗粒剂、配方颗粒剂中二者的质量浓度之和分别为传统汤剂的1.09，1.12倍。结论：比较吴茱萸碱和吴茱萸次碱的含量时，颗粒剂与传统汤剂相差较大，而配方颗粒剂与传统汤剂基本一致；比较人参皂苷Re和人参皂苷Rb1的含量时，颗粒剂、配方颗粒剂与传统汤剂基本一致。

Abstract

Objective: To compare the contents of index components in granule

dispensing granule and traditional decoction of Wuzhuyu Tang. Method: The contents of evodiamine

rutaecarpine

ginsenoside Re and ginsenoside Rb1 in these three forms of Wuzhuyu Tang were determined by HPLC. Result: The total contents of evodiamine and rutaecarpine in granule

dispensing granule and traditional decoction of Wuzhuyu Tang were 47.32

13.49

12.60 mg·L-1

the total contents of ginsenoside Re and ginsenoside Rb1 in these three forms of Wuzhuyu Tang were 335.23

345.28

307.39 mg·L-1. Conclusion: The granule is obviously different from the traditional decoction in terms of the content of evodiamine and rutaecarpine

while other index component are basically identical.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Study on Liver Injury of Different Components of Evodia Fructus in Vivo and in Vitro

Simultaneous Determination of Evodiamine,Rutaecarpine and Evodin in Cut Crude Drug and Exact of Fructus Evodiae by High-performance Liquid Chromatography

Study on the in vitro Release and Transdermal Permeability of Zuojin Micro-emulsive Gel and Zuojin Aqueous Gel

Comparison the Content of Evodiamine and Rutaecarpine from Compatible Granule, Compound Granule and Traditional Decoction of Zuojin Pills

Optimization of Extraction and Purification Technology of Active Components from by Multi-indexes

Related Author

Shu-ting WEI

Yun-hua SHENG

Jian HUANG

Li-ming TANG

BAO Tian-dong

DONG Yu

Yang Qing

ZHU Xiao-xin

Related Institution

Shanghai Institute of Food and Drug Control

China State Institute of Pharmaceutical Industry

Guiyang College of Traditional Chinese Medicine

Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medical/Traditional Chinese Medicine（TCM） Processing Technology Inheritance Base of National Administration of TCM， School of Chinese Materia Medica， Beijing University of Chinese Medicine

School of TCM，Capital Medical University

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰